Jennifer Bright discusses the following three trends that began in 2019 and will pick up steam this year:

  1. Increased demand for value information for drugs;
  2. Increased number of voices asking whether value assessment is done the right way; and
  3. Momentum to improve value assessment models.

Read the full article here. Please note that a Scrip subscription is required.